213 related articles for article (PubMed ID: 28601635)
1. Silencing HIF-1α induces TET2 expression and augments ascorbic acid induced 5-hydroxymethylation of DNA in human metastatic melanoma cells.
Fischer AP; Miles SL
Biochem Biophys Res Commun; 2017 Aug; 490(2):176-181. PubMed ID: 28601635
[TBL] [Abstract][Full Text] [Related]
2. Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells.
Miles SL; Fischer AP; Joshi SJ; Niles RM
BMC Cancer; 2015 Nov; 15():867. PubMed ID: 26547841
[TBL] [Abstract][Full Text] [Related]
3. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
Fischer AP; Miles SL
Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
5. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.
Minor EA; Court BL; Young JI; Wang G
J Biol Chem; 2013 May; 288(19):13669-74. PubMed ID: 23548903
[TBL] [Abstract][Full Text] [Related]
6. Effects of hypoxia on DNA hydroxymethylase Tet methylcytosine dioxygenase 2 in a KG-1 human acute myeloid leukemia cell line and its mechanism.
He P; Lei J; Zou LX; Zhou GZ; Peng L; Deng Q; Liu XL
Oncol Lett; 2021 Oct; 22(4):692. PubMed ID: 34457047
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.
Mills CN; Joshi SS; Niles RM
Mol Cancer; 2009 Nov; 8():104. PubMed ID: 19919690
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.
Blaschke K; Ebata KT; Karimi MM; Zepeda-Martínez JA; Goyal P; Mahapatra S; Tam A; Laird DJ; Hirst M; Rao A; Lorincz MC; Ramalho-Santos M
Nature; 2013 Aug; 500(7461):222-6. PubMed ID: 23812591
[TBL] [Abstract][Full Text] [Related]
9. Reversal of TET-mediated 5-hmC loss in hypoxic fibroblasts by ascorbic acid.
Liu Y; Xu S; Zu T; Li F; Sang S; Liu C; An Y; Mi B; Orgill DP; Murphy GF; Lian CG
Lab Invest; 2019 Jul; 99(8):1193-1202. PubMed ID: 30837678
[TBL] [Abstract][Full Text] [Related]
10. Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.
Zhong X; Wang QQ; Li JW; Zhang YM; An XR; Hou J
Sci Rep; 2017 Mar; 7():43539. PubMed ID: 28272491
[TBL] [Abstract][Full Text] [Related]
11. HIF-1 directly induces TET3 expression to enhance 5-hmC density and induce erythroid gene expression in hypoxia.
Cao JZ; Liu H; Wickrema A; Godley LA
Blood Adv; 2020 Jul; 4(13):3053-3062. PubMed ID: 32634239
[TBL] [Abstract][Full Text] [Related]
12. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
Mariani CJ; Vasanthakumar A; Madzo J; Yesilkanal A; Bhagat T; Yu Y; Bhattacharyya S; Wenger RH; Cohn SL; Nanduri J; Verma A; Prabhakar NR; Godley LA
Cell Rep; 2014 Jun; 7(5):1343-1352. PubMed ID: 24835990
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia induces the expression of TET enzymes in HepG2 cells.
Lin G; Sun W; Yang Z; Guo J; Liu H; Liang J
Oncol Lett; 2017 Dec; 14(6):6457-6462. PubMed ID: 29163682
[TBL] [Abstract][Full Text] [Related]
14. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
[TBL] [Abstract][Full Text] [Related]
15. TET-mediated DNA demethylation plays an important role in arsenic-induced HBE cells oxidative stress via regulating promoter methylation of OGG1 and GSTP1.
Wang Q; Wang W; Zhang A
Toxicol In Vitro; 2021 Apr; 72():105075. PubMed ID: 33388378
[TBL] [Abstract][Full Text] [Related]
16. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
[TBL] [Abstract][Full Text] [Related]
17. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
18. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
19. TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis.
Mahfoudhi E; Talhaoui I; Cabagnols X; Della Valle V; Secardin L; Rameau P; Bernard OA; Ishchenko AA; Abbes S; Vainchenker W; Saparbaev M; Plo I
DNA Repair (Amst); 2016 Jul; 43():78-88. PubMed ID: 27289557
[TBL] [Abstract][Full Text] [Related]
20. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.
Kumar SM; Yu H; Edwards R; Chen L; Kazianis S; Brafford P; Acs G; Herlyn M; Xu X
Cancer Res; 2007 Apr; 67(7):3177-84. PubMed ID: 17409425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
